Brief: Hikma Pharmaceutical Narrows FY2026 Group Operating Profit Range To $740 Million-$760 Million
Today 07:36
BRIEF-Hikma Pharmaceutical Narrows FY2026 Group Operating Profit Range To $740 Million-$760 Million Nov 5 (Reuters) - Hikma Pharmaceuticals PLC HIK.L:
HIKMA PHARMACEUTICAL - TRADING STATEMENT
HIKMA - NARROWS FY2026 GROUP OPERATING PROFIT RANGE TO $740 MILLION-$760 MILLION
HIKMA - REITERATES FY2026 GROUP REVENUE GROWTH OUTLOOK OF 2%-4%
HIKMA - CONFIRMS BECKY HALL TO JOIN AS CFO ON MARCH 8, 2027
Source text: ID:nRSE8602Ba
Further company coverage: HIK.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hikma Pharmaceuticals
See all newsUK's Hikma drops after tightening annual profit forecast
UK Stocks-Factors to watch on November 5 (updated)
UK's Hikma tightens annual profit outlook as branded medicines drive growth
Brief: Hikma Pharmaceutical Narrows FY2026 Group Operating Profit Range To $740 Million-$760 Million
Hikma Pharmaceutical - Trading Statement